Susquehanna International Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-157,100
| Closed | -$534K | – | 10588 |
|
|
2018
Q3 | $534K | Buy |
157,100
+24,900
| +19% | +$89.8K | ﹤0.01% | 6396 |
|
|
2018
Q2 | $497K | Sell |
132,200
-78,000
| -37% | -$380K | ﹤0.01% | 6800 |
|
|
2018
Q1 | $860K | Sell |
210,200
-16,800
| -7% | -$78.2K | ﹤0.01% | 5579 |
|
|
2017
Q4 | $1.06M | Buy |
227,000
+60,000
| +36% | +$331K | ﹤0.01% | 5126 |
|
|
2017
Q3 | $1.19M | Sell |
167,000
-65,800
| -28% | -$473K | ﹤0.01% | 4965 |
|
|
2017
Q2 | $1.68M | Sell |
232,800
-80,000
| -26% | -$500K | ﹤0.01% | 4233 |
|
|
2017
Q1 | $1.93M | Sell |
312,800
-5,200
| -2% | -$28.5K | ﹤0.01% | 3806 |
|
|
2016
Q4 | $1.86M | Sell |
318,000
-123,000
| -28% | -$672K | ﹤0.01% | 4219 |
|
|
2016
Q3 | $2.34M | Buy |
441,000
+196,400
| +80% | +$1.06M | ﹤0.01% | 3296 |
|
|
2016
Q2 | $1.62M | Buy |
244,600
+1,400
| +0.6% | +$7.83K | ﹤0.01% | 3945 |
|
|
2016
Q1 | $1.14M | Sell |
243,200
-64,900
| -21% | -$259K | ﹤0.01% | 4828 |
|
|
2015
Q4 | $1.56M | Buy |
308,100
+48,200
| +19% | +$229K | ﹤0.01% | 4554 |
|
|
2015
Q3 | $915K | Sell |
259,900
-88,700
| -25% | -$594K | ﹤0.01% | 5943 |
|
|
2015
Q2 | $3.48M | Sell |
348,600
-51,000
| -13% | -$547K | ﹤0.01% | 3571 |
|
|
2015
Q1 | $5.09M | Sell |
399,600
-237,300
| -37% | -$3.05M | ﹤0.01% | 2719 |
|
|
2014
Q4 | $9.01M | Sell |
636,900
-149,100
| -19% | -$2.31M | ﹤0.01% | 2148 |
|
|
2014
Q3 | $10.8M | Buy |
786,000
+186,100
| +31% | +$2.85M | ﹤0.01% | 2028 |
|
|
2014
Q2 | $9.23M | Buy |
599,900
+90,900
| +18% | +$1.29M | ﹤0.01% | 2213 |
|
|
2014
Q1 | $8.67M | Sell |
509,000
-211,800
| -29% | -$3.2M | ﹤0.01% | 2182 |
|
|
2013
Q4 | $9.33M | Buy |
720,800
+64,400
| +10% | +$769K | ﹤0.01% | 2156 |
|
|
2013
Q3 | $6.63M | Buy |
656,400
+170,700
| +35% | +$1.52M | ﹤0.01% | 2357 |
|
|
2013
Q2 | $3.63M | Buy |
+485,700
| New | +$3.8M | ﹤0.01% | 3041 |
|
Susquehanna International Group's KERX Position: Q3 2018 in Review
Susquehanna International Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 88,499 shares — an estimated $319K sold.
Susquehanna International Group first reported a position in KERX in Q2 2013 and held it in 20 quarters. The position peaked at $11.6M in Q4 2013. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.
- Susquehanna International Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
- Susquehanna International Group sold 88,499 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $319K.
- Susquehanna International Group first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 20 quarters.
- Susquehanna International Group's Keryx Biopharmaceuticals Inc position peaked at $11.6M in Q4 2013.
- 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.
Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.